Spruce Biosciences, Inc.: stockholders equity

What this measure means

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Exact concept: us-gaap:StockholdersEquity. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2018-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• Spruce Biosciences, Inc.: total assets
• Spruce Biosciences, Inc.: total liabilities
• Spruce Biosciences, Inc.: cash and cash equivalents
• Spruce Biosciences, Inc.: net income or loss
• Spruce Biosciences, Inc.: operating cash flow
• Spruce Biosciences, Inc.: capital expenditure payments
• Spruce Biosciences, Inc.: revenue
• Spruce Biosciences, Inc.: financing cash flow
• Spruce Biosciences, Inc.: investing cash flow
• Spruce Biosciences, Inc.: retained earnings or deficit
• Spruce Biosciences, Inc.: basic weighted-average shares
• Spruce Biosciences, Inc.: diluted weighted-average shares
• Spruce Biosciences, Inc.: basic earnings per share
• Spruce Biosciences, Inc.: diluted earnings per share
• Spruce Biosciences, Inc.: share-based compensation expense
• Spruce Biosciences, Inc.: operating income or loss
• Spruce Biosciences, Inc.: current assets
• Spruce Biosciences, Inc.: interest expense
• Spruce Biosciences, Inc.: current liabilities
• Spruce Biosciences, Inc.: current accounts payable
• Spruce Biosciences, Inc.: operating expenses
• Spruce Biosciences, Inc.: research and development expense

Inspect the source

Entity

Spruce Biosciences, Inc. / CIK 0001683553

Captured

2026-09-21T17:23:15.253Z

SEC response SHA-256

bbf81d1983f8fc4b803e7650343a136a77d45d173fd9a910547c0ee90b345088

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001683553.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))